Genertec Universal Medical Group Company Limited (HKG:2666)
Hong Kong · Delayed Price · Currency is HKD 4.705
-0.030 (-0.63%)
Sep 9, 2026, 3:35 PM HKT
HKG:2666 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Interest Expense | 63.8 | 69.35 | 50.71 | 39.05 | 35.65 | 29.13 |
Net Interest Income | -63.8 | -69.35 | -50.71 | -39.05 | -35.65 | -29.13 |
Other Revenue | 14,460 | 14,940 | 13,663 | 13,650 | 12,073 | 9,914 |
Revenue Before Loan Losses | 14,396 | 14,870 | 13,613 | 13,611 | 12,038 | 9,885 |
Provision for Loan Losses | 353.47 | 331.32 | 322.98 | 192.1 | 307.14 | 318.24 |
| 14,042 | 14,539 | 13,290 | 13,419 | 11,730 | 9,567 | |
Revenue Growth | -2.35% | 9.40% | -0.96% | 14.40% | 22.61% | 16.06% |
Cost of Services Provided | 11,328 | 11,713 | 10,781 | 10,644 | 8,934 | 6,917 |
Other Operating Expenses | -99.15 | - | 242.33 | - | - | - |
Total Operating Expenses | 11,229 | 11,713 | 11,023 | 10,644 | 8,934 | 6,917 |
Operating Income | 2,813 | 2,826 | 2,267 | 2,775 | 2,796 | 2,650 |
Earnings From Equity Investments | -9.92 | -9.09 | 26.56 | 6.38 | 13.46 | 13.87 |
Currency Exchange Gain (Loss) | 143.29 | 195.79 | - | - | - | 30.61 |
EBT Excluding Unusual Items | 3,023 | 3,018 | 2,869 | 2,842 | 2,691 | 2,683 |
Gain (Loss) on Sale of Investments | 1.03 | 1.03 | 6.31 | 24.41 | 11.66 | 8.37 |
Other Unusual Items | - | - | 31.93 | - | 0.95 | - |
Pretax Income | 3,024 | 3,019 | 2,907 | 2,866 | 2,703 | 2,692 |
Income Tax Expense | 695.95 | 701.56 | 648.79 | 667.14 | 617.33 | 661.34 |
Earnings From Continuing Ops. | 2,328 | 2,318 | 2,258 | 2,199 | 2,086 | 2,030 |
Minority Interest in Earnings | -94.08 | -108.64 | -154.38 | -88.74 | -126.13 | -82.74 |
Net Income | 2,234 | 2,209 | 2,104 | 2,110 | 1,960 | 1,948 |
Preferred Dividends & Other Adjustments | 42.55 | 52.19 | 72.22 | 89.42 | 71.4 | 112.5 |
Net Income to Common | 2,191 | 2,157 | 2,032 | 2,021 | 1,888 | 1,835 |
Net Income Growth | 3.23% | 6.15% | 0.53% | 7.02% | 2.90% | 11.39% |
Shares Outstanding (Basic) | 1,970 | 1,908 | 1,892 | 1,892 | 1,892 | 1,860 |
Shares Outstanding (Diluted) | 2,020 | 2,013 | 2,010 | 2,083 | 2,077 | 2,038 |
Shares Change | 0.69% | 0.14% | -3.49% | 0.28% | 1.93% | 18.73% |
EPS (Basic) | 1.11 | 1.13 | 1.07 | 1.07 | 1.00 | 0.99 |
EPS (Diluted) | 1.09 | 1.08 | 1.02 | 0.99 | 0.93 | 0.91 |
EPS Growth | 1.86% | 6.31% | 2.88% | 6.73% | 1.44% | -4.76% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2,546 | 4,787 | -116.76 | 4,097 | 1,414 | -1,786 |
Free Cash Flow Per Share | 1.26 | 2.38 | -0.06 | 1.97 | 0.68 | -0.88 |
Dividend Per Share | 0.324 | 0.324 | 0.329 | 0.318 | 0.301 | 0.293 |
Dividend Growth | -1.64% | -1.64% | 3.52% | 5.63% | 2.55% | 12.35% |
Operating Margin | 20.03% | 19.44% | 17.05% | 20.68% | 23.84% | 27.70% |
Profit Margin | 15.60% | 14.83% | 15.29% | 15.06% | 16.10% | 19.18% |
Free Cash Flow Margin | 18.13% | 32.93% | -0.88% | 30.53% | 12.06% | -18.67% |
Effective Tax Rate | 23.02% | 23.24% | 22.32% | 23.28% | 22.84% | 24.57% |